Weight-Loss drug trial aims to boost IVF success
NCT ID NCT07242534
Summary
This study is testing whether taking the weight-loss medication semaglutide for 12 weeks before IVF treatment can improve the quality of embryos for overweight and obese women. Researchers will compare women who receive the drug to those who do not, focusing on the number of high-quality embryos produced. The goal is to see if managing weight before IVF leads to better outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Departamento de Ginecología Obstetricia y Reproducción. Hospital Universitari Dexeus
RECRUITINGBarcelona, 08028, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Dexeus Mujer Reus
NOT_YET_RECRUITINGReus, Tarragona, 43202, Spain
Contact Email: •••••@•••••
Contact
-
Dexeus Mujer Sabadell
NOT_YET_RECRUITINGSabadell, Barcelona, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Dexeus Mujer Sant Cugat
NOT_YET_RECRUITINGSant Cugat del Vallès, Barcelona, 08195, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Dexeus Mujer Tarragona
NOT_YET_RECRUITINGTarragona, 43206, Spain
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.